List the golden-period windows (face ≤6 h, trunk ≤12 h, scalp ≤24 h); distinguish wounds within APP scope from those requiring referral.
Examine distal pulse, capillary refill, tendon ROM against resistance, two-point discrimination, joint capsule integrity — refer on any positive.
Calculate the maximum dose — 4.5 mg/kg plain, 7 mg/kg with epi; identify the epi-forbidden sites: fingers, toes, ears, nose, penis.
Execute simple interrupted, running, and vertical / horizontal mattress sutures with eversion, equal bite, and knots laid to the side of the wound.
Clip (not shave) hair, approximate edges with Adson forceps, fire staples perpendicular at 5–7 mm spacing without strangulating tissue.
Lead a TJC UP.01.03.01 time-out with calculated dose and allergy check; activate the ASRA LAST protocol on any prodrome.
| Screen | What you do | Disposition |
|---|---|---|
| Mechanism & time | Date the injury; assess contamination level (clean / contaminated / grossly contaminated); ask about retained foreign material (glass, gravel, soil). | Within golden period — proceed; over window — delayed primary or secondary intention; gross contamination — irrigate, pack, close at 3–5 d. |
| Size · depth | Measure length in cm; probe depth; describe wound bed and edges (clean-edged vs ragged / stellate). | Ragged or stellate edges → conservative debridement; depth involving deep fascia → layered closure with absorbable deep layer. |
| Vascular integrity | Distal pulse; capillary refill at the digit / nail bed distal to the wound; brisk vs delayed. | Any deficit — refer: named-vessel involvement is outside APP scope. |
| Deep-structure screen † | Tendon ROM against resistance at the affected site; two-point discrimination distal to the wound; joint capsule integrity; foreign-body imaging if mechanism warrants. | Any positive → refer to ED, Hand Surgery, or Plastic Surgery. Critical action on the Skills Validation Checklist. |
Perioral numbness · tinnitus · metallic taste · diplopia · seizure · arrhythmia. 20% lipid emulsion 1.5 mL/kg bolus, then 0.25 mL/kg/min per ASRA 2020.
| Face | 5-0 or 6-0 nylon / polypropylene · simple interrupted |
| Scalp | 3-0 or 4-0 nylon or staples |
| Trunk | 4-0 nylon / polypropylene |
| Extremity | 4-0 or 5-0 nylon |
| Deep layer | 4-0 Vicryl or Monocryl (absorbable) |
Edges that turn outward heal flush. Edges that invert heal depressed. Achieve eversion by perpendicular needle entry, depth equal to width, and gentle tissue handling with toothed Adson forceps.
| Face | 5 days |
| Scalp | 7–10 days |
| Trunk | 7–10 days |
| Extremity | 10–14 days |
| High-tension / joint | 10–14 days + steri-strips after removal |
Cellulitis, abscess, or purulent drainage. OPPE ceiling ≤ 5% over rolling 12 mo.
Separation at / before scheduled removal. OPPE ceiling ≤ 3%.
Patient-specific risk — anterior chest, deltoid, earlobe. Counsel pre-procedure.
Left too long or tied too tight. Mattress sutures removed earlier than interrupted.
Single prodrome triggers mandatory focused review of the index case + 3 subsequent closures. Activate ASRA 2020 protocol; 20% lipid emulsion 1.5 mL/kg bolus then 0.25 mL/kg/min.
| Stage | Trigger | Scope |
|---|---|---|
| FPPE | Board approval of suturing / staple privilege | First 3 independent cases · scalp + extremity + face mix where volume allows · within 6 mo |
| OPPE | Continuous baseline | Every 6 mo · 10% sample (min 2, max 10) · 100% review of any complication-flagged case |
| Trigger review | LAST · epi-forbidden site · missed deep-structure · I&D-level infection | Index case + next 3 closures reviewed |
| Reinstatement | < 10 closures in rolling 24 mo | Stream B skills checklist + 1 proctored case rated Independent |
| Renewal | Biennial · 22 CCR §70703 (CA) | OPPE indicators aggregate · Chair sign-off |